Since the surface expression of CD45 significantly decreases in o-WAT in pre-T2D and T2D groups, this indicates a decrease in the effector function of mast cells in o-WAT with subtle changes in the glycemic control. The gene discussed is PTPRC; the disease is type 2 diabetes mellitus.